Advertisement

Reverse TME: The “Bottom-UP” Approach to Low Rectal Cancer

  • Maria Clara Arroyave
  • F. Borja de Lacy
  • Antonio M. LacyEmail author
Chapter

Abstract

Colorectal cancer is the third most common type of cancer diagnosed in United States, and with rectal cancer accounting for approximately the 30% of the cases. In 2016, the American Cancer Society estimated almost 40,000 of new rectal cancer cases, the majority undergoing surgery – a surgery that has traditionally been difficult, especially in cases of obesity, males and with narrow pelvis. The oncologic cornerstone of this surgery is the removal of the mesorectum as an intact specimen en-bloc with a margin-free tumour. Systematic adherence to this principle has been proven to prolong survival and reduce locoregional recurrence.

References

  1. 1.
    Sylla P, Rattner DW, Delgado S, Lacy AM. NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc. 2010;24:1205–10.CrossRefGoogle Scholar
  2. 2.
    Buess G, Kipfmüller K, Hack D, et al. Technique of transanal endoscopic microsurgery. Surg Endosc. 1988;2(2):71–5.CrossRefGoogle Scholar
  3. 3.
    Marks GJ, Marks JH, Mohiuddin M, et al. Radical sphincter preservation surgery with coloanal anastomosis following high-dose external irradiation for the very low lying rectal cancer. Recent Results Cancer Res. 1998;146:161–74.CrossRefGoogle Scholar
  4. 4.
    Whiteford MH, Denk PM, Swanstrom LL. Feasibility of radical sigmoid colectomy performed as natural orifice translumenal endoscopic surgery (NOTES) using transanal endoscopic microsurgery. Surg Endosc. 2007;21:1870–4.CrossRefGoogle Scholar
  5. 5.
    Atallah S, Larach S, Albert M. Transanal minimally invasive surgery: a giant leap forward. Surg Endosc. 2010;24:2200–5.CrossRefGoogle Scholar
  6. 6.
    Heald RJ. A new approach to rectal cancer. Br J Hosp Med. 1979;22:277–28.PubMedGoogle Scholar
  7. 7.
    Green BL, Marshall HC, Collinson F, et al. Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg. 2013;100(1):75–82.CrossRefGoogle Scholar
  8. 8.
    Guillou PJ, Quirke P, Thorpe H, et al. MRC CLASICC trial group. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet. 2005;365(9472):1718–26.CrossRefGoogle Scholar
  9. 9.
    van der Pas MH, Haglind E, Cuesta MA, et al. COlorectal cancer Laparoscopic or Open Resection II (COLOR II) Study Group. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol. 2013;14(3):210–8.CrossRefGoogle Scholar
  10. 10.
    Kang SB, Park JW, Jeong SY, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol. 2010;11:637–45.CrossRefGoogle Scholar
  11. 11.
    Kim JS, Cho SY, Min BS, et al. Risk factors for anastomotic leakage after laparoscopic intracorporeal colorectal anastomosis with a double stapling technique. J Am Coll Surg. 2009;209(6):694–701.CrossRefGoogle Scholar
  12. 12.
    Schiessel R, Karner-Hanusch J, Herbst F, et al. Intersphincteric resection for low rectal tumours. Br J Surg. 1994;81(9):1376–8.CrossRefGoogle Scholar
  13. 13.
    Akagi Y, Shirouzu K, Ogata Y, et al. Oncologic outcomes of intersphincteric resection without preoperative chemoradiotherapy for very low rectal cancer. Surg Oncol. 2013;22(2):144–9.CrossRefGoogle Scholar
  14. 14.
    Marks G, Mohiuddin M, Goldstein SD. Sphincter preservation for cancer of the distal rectum using high dose preoperative radiation. Int J Radiat Oncol Biol Phys. 1988;15(5):1065–8.CrossRefGoogle Scholar
  15. 15.
    Tasende MM, Delgado S, Jimenez M, et al. Minimal invasive surgery: NOSE and NOTES in ulcerative colitis. Surg Endosc. 2015;29:3313–8.CrossRefGoogle Scholar
  16. 16.
    Bravo R, Fernández-Hevia M, Jiménez-Toscano M, et al. Transanal Hartmann reversal: a new technique. Surg Endosc. 2016;30(6):2628–31.Google Scholar
  17. 17.
    Borstlap WA, Harran N, Tanis PJ, Bemelman WA. Feasibility of the TAMIS technique for redo pelvic surgery. Surg Endosc. 2016;30(12):5364–71.CrossRefGoogle Scholar
  18. 18.
    Jafari MD, Wexner SD, Martz JE, et al. Perfusion assessment in laparoscopic left-sided/anterior resection (PILLAR II): a multi-institutional study. J Am Coll Surg. 2015;220(1):82–92.CrossRefGoogle Scholar
  19. 19.
    Rouanet P, Mourregot A, Azar CC, et al. Transanal endoscopic proctectomy: an innovative procedure for difficult resection of rectal tumors in men with narrow pelvis. Dis Colon Rectum. 2013;56:408–15.CrossRefGoogle Scholar
  20. 20.
    Simillis C, Hompes R, Penna M, et al. A systematic review of transanal total mesorectal excision: is this the future of rectal cancer surgery? Color Dis. 2016;18(1):19–36.CrossRefGoogle Scholar
  21. 21.
    Velthuis S, Veltcamp Helbach M, Tuynman JB, et al. Intra-abdominal bacterial contamination in TAMIS total mesorectal excision for rectal carcinoma: a prospective study. Surg Endosc. 2015;29(11):3319–23.CrossRefGoogle Scholar
  22. 22.
    Nagtegaal ID, van de Velde CJH, van der Worp E, et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol. 2002;20:1729–37.CrossRefGoogle Scholar
  23. 23.
    Tuech JJ, Karoui M, Lelong B, et al. A step toward NOTES total mesorectal excision for rectal cancer. Endoscopic transanal proctectomy. Ann Surg. 2015;261:228–33.CrossRefGoogle Scholar
  24. 24.
    Veltcamp Helbach M, Deijen CL, Velthuis S, et al. Transanal total mesorectal excision for rectal adenocarcinoma: short-term outcomes and experience after 80 cases. Surg Endosc. 2016;30(2):464–70.CrossRefGoogle Scholar
  25. 25.
    Lacy AM, Tasende MM, Delgado S, et al. Transanal total mesorectal excision for rectal cancer: outcome after 140 patients. J Am Coll Surg. 2015;221(2):415–23.CrossRefGoogle Scholar
  26. 26.
    Elmore U, Fumagalli Romario U, Vignali A, et al. Laparoscopic anterior resection with transanal total mesorectal excision for rectal cancer: preliminary experience and impact on postoperative bowel function. J Laparoendosc Adv Surg Tech A. 2015;25(5):364–9.CrossRefGoogle Scholar
  27. 27.
    Zhang H, Zhang YS, Jin XW, et al. Transanal single-port laparoscopic total mesorectal excision in the treatment of rectal cancer. Tech Coloproctol. 2013;17:117–23.CrossRefGoogle Scholar
  28. 28.
    Chouillard E, Chahine E, Khoury G, et al. Notes total mesorectal excision (TME) for patients with rectal neoplasia: a preliminary experience. Surg Endosc. 2014;28:3150–7.CrossRefGoogle Scholar
  29. 29.
    Leroy J, Barry BD, Melani A, et al. No-scar transanal total mesorectal excision: the last step to pure NOTES for colorectal surgery. JAMA Surg. 2013;148:226–30; discussion 31.Google Scholar
  30. 30.
    Collinson FJ, Jayne DG, Pigazzi A, et al. An international, multicentre, prospective, randomised, controlled, unblinded, parallel-group trial of robotic-assisted versus standard laparoscopic surgery for the curative treatment of rectal cancer. Int J Color Dis. 2012;27(2):233–41.CrossRefGoogle Scholar
  31. 31.
    Huscher CG, Bretagnol F, Ponzano C. Robotic-assisted transanal total mesorectal excision: the key against the Achilles’ heel of rectal cancer. Ann Surg. 2015;261(5):e120–1.CrossRefGoogle Scholar
  32. 32.
    Gómez Ruiz M, Parra IM, Palanzuelos CM, et al. Robotic-assisted laparoscopic transanal total mesorectal excision for rectal cancer: a prospective pilot study. Dis Colon Rectum. 2015;58(1):145–53.CrossRefGoogle Scholar
  33. 33.
    Atallah S, Nassif G, Polavarapu H, et al. Robotic-assisted transanal surgery for total mesorectal excision (RATS-TME): a description of a novel surgical approach with video demonstration. Tech Coloproctol. 2013;17(4):441–7.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Maria Clara Arroyave
    • 1
  • F. Borja de Lacy
    • 2
  • Antonio M. Lacy
    • 3
    Email author
  1. 1.Department of Surgical OncologyAIS Channel, Clinica SomerRionegroColombia
  2. 2.Department of Gastrointestinal SurgeryICMDM, AIS Channel, Hospital ClínicBarcelonaSpain
  3. 3.Department of Gastrointestinal SurgeryICMDM, IDIBAPS, CIBEREHD, AIS Channel, Hospital Clínic, Universitat de BarcelonaBarcelonaSpain

Personalised recommendations